ArticleAmerican journal of translational research2021

Anlotinib suppresses MLL-rearranged acute myeloid leukemia cell growth by inhibiting SETD1A/AKT-mediated DNA damage response.

Jinzhu Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.